The Osteopathic Diagnosis and Treatment of Neurolymphatic Diseases
Registration |
---|
Cost
To register, email Dr. RubyTam at ruby.mecfsclinicmn@gmail.com. |
Target Audience
The course is suitable for osteopaths, physical therapists, occupational therapists, massage therapists, cranial sacral therapists, lymph specialists, and chiropractors with basic knowledge and some experience in basic cranial techniques.
Description
The Perrin TechniqueTM for the Diagnosis and Treatment of ME/CFS was developed in 1989. In this workshop, you will learn how to examine patients for physical signs that aid in the diagnosis of ME/CFS and Fibromyalgia. These signs have been confirmed in an NHS study at Wrightington Hospital, UK, published in the BMJ Open (Hives L et al. Nov 2017), which will be discussed in detail. Also, in this two-day workshop, you will learn how to manually treat complex conditions such as ME/CFS, FMS, Long-COVID, and Lymes Disease, and help with comorbidities such as POTS and EDS.
The workshop will cover the neuroscience underlying the physical symptoms and diagnostic signs to screen for ME/CFS and Fibromyalgia and Long-COVID. It includes practical sessions with clinical handouts for practitioners to aid the diagnostic and prognostic process. The full treatment protocol taught in the Workshop by Dr. Perrin will be life-changing for many of your patients.
In this 2-day workshop, Dr. Perrin will detail the evidence-based diagnosis, treatment, and management of Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME), fibromyalgia, and, now, long-term COVID-19.
The planned workshop will be divided into three parts:
1. Applied anatomy and pathophysiology of the neurolymphatic and autonomic nervous system:
a. The pathogenesis of ME/CFS from a biomechanical perspective will be presented.
b. The physical symptoms underlying the illnesses and diagnostic signs will be explained.
2. The evidence to support the physical diagnostic criteria:
a. A summary of the clinical trials at the Universities of Salford and Manchester and the results of an independently controlled clinical study in Hammersmith Hospital, London, will be presented.
b. A review of the diagnostic study published in the BMJ Open (Hives L et al. Nov 2017) will be presented.
3. Practical session:
a. The consultation process and clinical diagnostic method will be demonstrated.
b. The Perrin TechniqueTM treatment protocol will be taught through practical sessions.
c. Examination and treatment require exposure of the whole breast tissue, which must be done with undergarments removed. Participants are not obligated to model for examination or treatment, but if they desire it, full information and a consent form will be provided before the course.
d. Management options for ME/CFS, FMS, and long COVID will be discussed, and an integrative, multidisciplinary approach will be demonstrated.
Learning Objectives
- Use the techniques demonstrated to screen patients for ME/CFS and Fibromyalgia syndrome (FMS) in their clinical practice.
- Examine the patient for the early physical symptoms and diagnostic signs for possible CFS/ME and Fibromyalgia.
- Identify etiological and maintaining factors that may have predisposed the patient to ME/CFS and FMS and increased their susceptibility to them.
- Assess the severity level of the patient’s illness and calculate the prognosis for their condition.
- Practice the manual treatment of the neuro-lymphatic system.
- Review the pathogenesis of CFS/ME and Fibromyalgia from a biomechanical perspective.
- Manage the CFS/ME and fibromyalgia patients to support patient well-being.
The times listed are in the local time. The agenda is subject to change.
DAY 1 | |
9:00 am | Registration |
9:30 am | Applied Anatomy and Physiology of the Sympathetic Nervous and Neuro-Lymphatic Systems |
11:00 am | Break |
11:15 am | The Pathogenesis of CFS/ME and Fibromyalgia |
12:30 pm | Lunch |
1:30 pm | Diagnosis: The Consultation Process |
3:30 pm | Break |
3:45 pm | Practical Training: Examination and Diagnosis |
5:30 pm | Adjourn |
DAY 2 | |
9:00 am | Coffee |
9:30 am | Practical Training: Examination and Diagnosis (Continued) |
10:45 am | Break |
11:00 am | Practical Training: 'The Perrin Technique' Treatment of CFS/ME and Fibromyalgia |
12:30 pm | Lunch |
1:30 pm | Practical Training: Treatment (Continued) |
3:45 pm | Break |
4:00 pm | Other Treatment Strategies for CFS/ME |
5:30 pm | Adjourn |
Raymond Perrin, DO (UK), PhD
- Neuroscientist and specialist in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- Hon. Clinical Research Fellow, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
- Vice Patron – University College of Osteopathy, London
- International Faculty member of The Osteopathie Schule Deutschland (OSD)
- Winner of the Institute of Osteopathy’s Research and Practice Award 2015
Dr. Raymond Perrin qualified in 1984 from the then-British School of Osteopathy (BSO). While at the BSO he spent three years working in the children’s clinic with Jonathan Curtis-Lake where he gained much experience in cranio-sacral techniques.
He has extensive experience treating top athletes, including Olympians. In 1991, he was appointed official osteopath to the World Student Games, Sheffield, UK.
Dr. Perrin’s research since 1989 in ME/CFS has expanded knowledge of the disease and how to diagnose and treat it. In July 2005, he was awarded a doctorate by the University of Salford, UK for his thesis on the involvement of cerebrospinal fluid and lymphatic drainage in ME/CFS.
From 1996 onwards, he has been the Research Director of F.O.R.M.E. Trust (The Fund for Osteopathic Research into Myalgic Encephalomyelitis).
Since 2007, he has held the academic post of Honorary Senior Lecturer at the Allied Health Professions Research Unit, University of Central Lancashire (UCLan), in Preston, UK.
He has lectured internationally and in the UK to patient groups for ME/CFS and the medical profession on the osteopathic treatment of ME/CFS. He has published papers in major medical journals and his book, The Perrin Technique: How to Beat CFS/ME was first published by Hammersmith Press, London in 2007 with the second edition being published in 2021.
In 2009, Dr. Perrin presented his work to the world’s leading experts in ME/CFS at the Annual Conference of the International Association of CFS/ME (IACFS/ME) in Reno, Nevada.
He was appointed member of the Scientific Committees for the 2nd, 3rd, and 4th World Congresses on Neurobiology and Psychopharmacology affiliated with the European Association of Psychiatrists Annual Conference, Greece.
In March 2014, Dr. Perrin presented further research findings at the IACFS/ME Annual Conference in San Francisco.
In a study between 2015-16, he was the chief investigator of a joint UCLan and National Health Service (NHS) research project: Examining the accuracy of a physical diagnostic technique for chronic fatigue syndrome/myalgic encephalomyelitis, REC reference number 12/NW/0877.
In 2015, he joined the international faculty of the German School of Osteopathy, Hamburg, teaching osteopathic theory and practice to students in colleges throughout Europe. Additionally, Dr, Perrin has lectured and taught worldwide including in the USA, South Africa, Gibraltar, Czech Republic, The Netherlands, Ireland, Sweden, Norway, Finland, Sicily, Russia, Australia, Brazil, and South Africa, to fellow osteopaths, physiotherapists, chiropractors and physicians in the manual techniques he has developed.
In his service to osteopathy, Dr. Perrin was appointed a vice-patron of The British School of Osteopathy, now The University College of Osteopathy, and was the proud recipient of the inaugural Research and Practice Award from the Institute of Osteopathy in 2015.
In 2016, he was a lecturer at the IACFS/ME Annual Conference in Fort Lauderdale, Florida, where he was invited to present his findings to the Neuroimmune Research Centre at the College of Osteopathic Medicine at NOVA Southeastern University. He detailed his ground-breaking research project in this workshop which was published in the online version of The British Medical Journal (Hives L et al 2017).
He is at present an Honorary Clinical Research Fellow in the Faculty of Biology, Medicine & Health at The University of Manchester.
Ray lives with his family in North Manchester where he runs a multi-disciplinary clinic. He also sees patients in two other clinics near London.
ACCREDITATION STATEMENTS
MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences (DMU) and ME/CFS Clinic Minnesota. DMU designates this activity for 13.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 13.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University Medicine and Health Sciences is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 13.0 continuing education contact hour(s). Nurses must attend the entire session to receive credit. Partial session credit is prohibited and will be forfeited.
- Other healthcare providers: This activity is designated for 13.0 AMA PRA Category 1 Credit(s)™.
EDUCATIONAL GRANTS
No ineligible company provided financial support for this continuing education activity.
DISCLOSURE
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Jennie Halbroeder - Planning Committee Member
- Raymond Perrin, DO (UK), PhD - Speaker
- Sally Rediske, MPT - Planning Committee Member
- Ruby W. Tam, DO - Activity Director and Planning Committee Member
DISCLAIMER
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 13.00 AMA PRA Category 1 Credits™
- 13.00 AOA Category 1A
- 13.00 CE Contact Hour(s)
- 13.00 IBON
Price
To register, email Dr. RubyTam at ruby.mecfsclinicmn@gmail.com.
Cost
- Early-Bird Registration: $550 (before June 1, 2024)
- Regular Registration: $600 (on or after June 1, 2024)
Cancellation Policy
You may cancel your registration before June 1, 2024, and receive a refund of the registration fee less a $50 processing fee. The registration fee is non-refundable on or after June 1, 2024, but you can transfer your registration to another individual. For any cancellation arrangements, please email us (see contact information below). We reserve the right to cancel any workshop, in which case the registration fee will be returned in full. We are not responsible for any guaranteed airline/hotel reservation.